Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...